Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations

Analytical Biochemistry

Volumn 388, Issue 1, 2009, Pages 140-145

  Volpi, Nicola ^a   Maccari, Francesca ^a   Linhardt, Robert J ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Anthranilic acid; Capillary electrophoresis; Galactosamine; Glucosamine; Heparin; Oversulfated chondroitin sulfate

Indexed keywords

ASCORBIC ACID; CAPILLARY ELECTROPHORESIS; GALACTOSAMINE; GLUCOSAMINE; POLYSACCHARIDES; SULFUR COMPOUNDS;

ANALYTICAL APPROACH; ANTHRANILIC ACID; CHONDROITIN SULFATES; ENZYMATIC TREATMENTS; HEPARIN; HIGH-SENSITIVITY DETECTION; LIMIT OF DETECTION; LIMIT OF QUANTIFICATIONS;

CONTAMINATION;

ANTHRANILIC ACID; CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; DERMATAN SULFATE; GALACTOSAMINE; GLUCOSAMINE; HEPARIN; POLYSACCHARIDE;

ACCURACY; ARTICLE; CAPILLARY ELECTROPHORESIS; DEGRADATION; DERIVATIZATION; DRUG CONTAMINATION; HYDROLYSIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY;

EID: 63149149990     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2009.02.012     Document Type: Article

References (22)

1. In: Ofosu F.A., Danishefsky I., and Hirsh J. (Eds). Heparin and Related Polysaccharides: Structure and Activities, vol. 556 (1989), New York Academy of Sciences, New York
2. Petitou M., Casu B., and Lindahl U. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. Biochimie 85 (2003) 83-89
3. Lindahl U. "Heparin": from anticoagulant drug into the new biology. Glycoconj. J. 17 (2000) 597-605
4. Unkle D.W. Heparin-induced thrombocytopenia. Orthop. Nurs. 26 (2007) 383-385
5. Hassan Y., Awaisu A., Aziz N.A., Aziz N.H., and Ismail O. Heparin-induced thrombocytopenia and recent advances in its therapy. J. Clin. Pharm. Ther. 32 (2007) 535-544
6. Weitz J.I. Low-molecular-weight heparins. N. Engl. J. Med. 337 (1997) 688-698
7. Hirsh J., and Levine M.N. Low molecular weight heparin. Blood 79 (1992) 1-17
8. Guerrini M., Beccati D., Shriver Z., Naggi A., Viswanathan K., Bisio A., Capila I., Lansing J.C., Guglieri S., Fraser B., Al-Hakim A., Gunay N.S., Zhang Z., Robinson L., Buhse L., Nasr M., Woodcock J., Langer R., Venkataraman G., Linhardt R.J., Casu B., Torri G., and Sasisekharan R. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat. Biotechnol. 26 (2008) 669-675
9. Kishimoto T.K., Viswanathan K., Ganguly T., Elankumaran S., Smith S., Pelzer K., Lansing J.C., Sriranganathan N., Zhao G., Galcheva-Gargova Z., Al-Hakim A., Bailey G.S., Fraser B., Roy S., Rogers-Cotrone T., Buhse L., Whary M., Fox J., Nasr M., Dal Pan G.J., Shriver Z., Langer R.S., Venkataraman G., Austen K.F., Woodcock J., and Sasisekharan R. Contaminated heparin associated with adverse clinical events and activation of the contact system. N. Engl. J. Med. 358 (2008) 2457-2467
10. Zhang Z., Weïwer M., Li B., Kemp M.M., Daman T.H., and Linhardt R.J. Oversulfated chondroitin sulfate: Impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation. J. Med. Chem. 51 (2008) 5498-5501
11. 1H-nuclear magnetic resonance spectroscopy. J. Pharm. Sci. 78 (1989) 101-104
12. Volpi N., Maccari F., and Linhardt R.J. Capillary electrophoresis of complex natural polysaccharides. Electrophoresis 29 (2008) 3095-3106
13. Maruyama T., Toida T., Imanari T., Yu G., and Linhardt R.J. Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation. Carbohydr. Res. 306 (1998) 35-43
14. Anumula K.R. Quantitative determination of monosaccharides in glycoproteins by high-performance liquid chromatography with highly sensitive fluorescence detection. Anal. Biochem. 220 (1994) 275-283
15. Biopharmaceutics Coordinating Committee in the Center for Drug Evaluation and Research in cooperation with the Center for Veterinary Medicine at the Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Washington, DC, 2001.
16. Buzzega D., Maccari F., and Volpi N. Fluorophore-assisted carbohydrate electrophoresis for the determination of molecular mass of heparins and low-molecular-weight (LMW) heparins. Electrophoresis 29 (2008) 4192-4202
17. Ruiz-Calero V., Puignou L., and Galceran M.T. Analysis of glycosaminoglycan monosaccharides by capillary electrophoresis using indirect laser-induced fluorescence detection. J. Chromatogr. A 873 (2000) 269-282
18. Racaityte K., Kiessig S., and Kálmán F. Application of capillary zone electrophoresis and reversed-phase high-performance liquid chromatography in the biopharmaceutical industry for the quantitative analysis of the monosaccharides released from a highly glycosylated therapeutic protein. J. Chromatogr. A 1079 (2005) 354-365
19. Sato K., Sato K., Okubo A., and Yamazaki S. Determination of monosaccharides derivatized with 2-aminobenzoic acid by capillary electrophoresis. Anal. Biochem. 251 (1997) 119-121
20. Sato K., Sato K., Okubo A., and Yamazaki S. Separation of 2-aminobenzoic acid-derivatized glycosaminoglycans and asparagine-linked glycans by capillary electrophoresis. Anal. Sci. 21 (2005) 21-24
21. Drummond K.J., Yates E.A., and Turnbull J.E. Electrophoretic sequencing of heparin/heparan sulfate oligosaccharides using a highly sensitive fluorescent end label. Proteomics 1 (2001) 304-310
22. N. Volpi, Capillary electrophoresis determination of glucosamine in nutraceutical formulations after labeling with anthranilic acid and UV detection, J. Pharm. Biomed. Anal., in press [Epub ahead of print].